Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Medical device company St. Jude Medical sues AorTech, the Scottish company that makes the Optim insulation for its next-generation Durata pacemaker leads, winning an injunction against the termination of their supply deal.
Some medical device industry stakeholders are "cautiously optimistic" that the 2.3% medical device tax can be repealed before it takes effect in January, as others remain "laser-focused" on bringing the measure down.
Boston Scientific executives tell MassDevice.com that the medical device company is aiming to have the 2nd renal denervation high blood pressure device on the U.S. market, behind arch-rival Medtronic, now that it’s agreed to pay up to $425 million for Vessix Vascular.